Waldencast plc
Waldencast plc (WALDW) Stock Overview
Explore Waldencast plc’s financial performance, market position, analyst ratings, and future outlook.
WALDW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Waldencast plc (WALDW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.18.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.74 and a market capitalization of 7.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
Mr. Michel Brousset
335
10 Bank Street, White Plains, NY
2021